We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized by the ...

Clinical research sites using RealTime's eSource application will gain expanded access to IgniteData's Archer platform.

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

The global clinical trial management services market is projected to grow from $36.2 billion in 2025 to $68.4 billion by 2033, a new Research and Markets report finds, with North America holding 34.7% ...

Yonalink is a technology company specializing in clinical trial data management. They provide a platform that streamlines the process of collecting, managing, and transferring clinical trial data, ...

IgniteData, a leader in intelligent clinical trial data automation, and RealTime eClinical Solutions, a leader in clinical research software solutions, today announced a new partnership which will ...

The initiative aims to address recruitment hurdles by enabling healthcare providers to spot suitable individuals with ease.

Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...

Capitalize on trial outsourcing, AI integration, decentralized models and Asia-Pacific expansion to improve recruitment, data accuracy and site efficiency.Dublin, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ...

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide ...

Poster presentation to highlight the Phase 1a clinical evaluation of TTX-MC138 in patients with advanced solid tumors. BOSTON, Oct. 19, 2026 /PRNewswire/ -- TransCode Therapeutics ...